HPRA regulatory notice: Peptides Lab Ireland supplies all compounds strictly for in-vitro laboratory and scientific research. They are not licensed medicines and are not for human or veterinary use.
BPC-157 is often described online as a “recovery peptide”. That phrase is everywhere, but it can be misleading. In science, “recovery” has a specific meaning: how quickly and how fully injured tissue returns to normal structure and function in a research model. This guide explains what BPC-157 is, where it came from, what “recovery” means in the research, what animal and laboratory studies have reported about recovery from injury, how researchers measure it, and why these findings should be read with care. All findings described here come from preclinical research. BPC-157 is not an approved medicine and is supplied for laboratory research only.
What is BPC-157?
BPC-157 is a synthetic peptide made of 15 amino acids. Its name stands for Body Protection Compound-157. Its sequence was based on part of a protein found in human gastric juice. It has a molecular weight of about 1419 Da.
It was first described by researchers in Zagreb, Croatia, in the early 1990s. Since then, that group and a smaller number of others have published many studies on it, mostly in rats.
What does “recovery” mean in BPC-157 research?
When researchers study recovery, they create a controlled injury in an animal model, then compare how the injured tissue recovers with and without the compound being studied. Measures of recovery include:
- Structure: how the tissue looks under a microscope, for example how well collagen fibres line up in a tendon.
- Strength: how much force the tissue can withstand before failing, tested mechanically.
- Function: how well the animal uses the injured limb, for example walking patterns.
- Time: how quickly these measures return towards normal.
- Biochemical markers: levels of molecules linked to inflammation, blood vessel growth or tissue formation.
So when a study reports that BPC-157 “supported recovery”, it usually means that one or more of these measures improved faster or further in the BPC-157 group than in the control group, in that specific model.
What are the stages of tissue recovery?
To understand what BPC-157 research measures, it helps to know how soft tissue normally heals. Healing usually happens in three overlapping stages:
1. Inflammation (first few days): blood vessels leak fluid and immune cells arrive to clear damaged tissue and release signals that start repair.
2. Proliferation (days to weeks): new blood vessels grow, and repair cells such as fibroblasts move in and lay down new collagen. The tissue at this stage is weak and disorganised.
3. Remodelling (weeks to months): the new collagen is reorganised and strengthened, and the tissue slowly becomes more like the original, although tendons and ligaments rarely return fully to normal.
Proposed BPC-157 effects, such as blood vessel growth and cell migration, would mainly act during the proliferation stage. This is why many studies measure outcomes in the first few weeks after injury.
What recovery models has BPC-157 been studied in?
Tendon injury
One of the best-known studies, published in 2003, cut the Achilles tendon in rats and found that BPC-157 was associated with better healing on several measures. The same study found that BPC-157 stimulated growth of tendon cells in the lab [2].
Ligament injury
Rat studies of the medial collateral ligament of the knee reported improved healing measures with BPC-157.
Muscle injury
Studies of crushed, cut or detached muscles in rats reported faster recovery of muscle structure and function.
Bone injury
Some studies looked at bone defects and reported effects on bone healing in rats and rabbits.
Nerve injury
Studies of cut or crushed nerves reported effects on nerve regeneration and function in rats.
Gut and skin injury
BPC-157 was also studied for recovery of the gut lining and skin wounds, as described in other reviews.
How might BPC-157 support recovery?
Researchers have proposed several mechanisms, mainly from animal and cell studies:
- Blood vessel growth: promoting angiogenesis, which brings oxygen and nutrients to injured tissue.
- Cell migration: helping repair cells, such as tendon fibroblasts, move into the injured area.
- Cell survival: helping cells survive under stress.
- Growth factor signalling: affecting pathways such as those involving VEGF and growth hormone receptors in tendon cells.
- Nitric oxide: interacting with the nitric oxide system, which affects blood flow.
For a deeper look at these mechanisms, see our comprehensive overview of BPC-157 and tissue repair.
How strong is the recovery evidence?
A 2025 systematic review of BPC-157 in orthopaedic sports medicine examined the published evidence. It found that most studies were in animals, mainly rats, and that clinical evidence was very limited and of low quality [1]. A 2025 narrative review, “Regeneration or Risk?”, reached a similar conclusion and stressed the need for better-designed studies and attention to safety [3].
Key limits include:
- Species: rat tendons, muscles and bones heal differently from those of larger animals.
- Injury models: surgical injuries in young, healthy rats differ from many real-world injuries.
- Single research group: most findings come from one group, with limited independent replication.
- Study size and design: many studies were small, and blinding was not always described.
What questions remain open?
- Does BPC-157 work the same way in larger animals?
- Which mechanism is most important, and does it have a specific receptor?
- Are effects seen with the intact peptide, its fragments, or downstream signals?
- How long do any effects last?
- What are the long-term safety effects, especially given its pro-angiogenic activity?
For a review of the safety evidence, see BPC-157 side effects: what the research actually shows.
Is “recovery” the same as better performance?
No. This is a common misunderstanding online. Recovery studies look at how injured tissue heals after a controlled injury in a research model. They do not show that a compound improves strength, speed or endurance in healthy animals, and they do not show any effect outside the research setting. Claims that BPC-157 improves athletic performance are not supported by the published research, and BPC-157 is on the World Anti-Doping Agency’s prohibited list.
Why do outcome measures sometimes disagree?
Different measures of recovery do not always move together. A tendon might look better organised under the microscope but not be any stronger in mechanical testing, or an animal might walk better while tissue structure looks similar. This is why studies using several types of measure give a more reliable picture than those using only one.
What should researchers consider when studying recovery?
- Choose relevant models, and consider larger animal models for musculoskeletal work.
- Use several outcome measures, combining structure, strength and function.
- Blind assessors, especially for scoring tissue under the microscope.
- Include safety outcomes.
- Use adequate sample sizes.
- Report full methods, including the source and quality of BPC-157.
- Measure at several time points, so the stages of healing can be followed rather than captured at a single moment.
How should BPC-157 be sourced and stored?
Use BPC-157 with a batch-specific Certificate of Analysis showing HPLC purity of 98% or higher and a mass of about 1419 Da. Store freeze-dried material cold, dry and protected from light. Our storage lifetime guide explains how long peptides typically last. Researchers in Ireland can order research-grade BPC-157 for laboratory research.
Frequently asked questions
Who first studied BPC-157?
Researchers in Zagreb, Croatia, who first described it in the early 1990s.
What does BPC stand for?
Body Protection Compound.
What does “recovery” mean in BPC-157 research?
How quickly and fully injured tissue returns to normal structure, strength and function in a research model.
What injury models has BPC-157 been studied in?
Tendon, ligament, muscle, bone, nerve, gut and skin injury models, mainly in rats.
How might BPC-157 support recovery in these models?
Proposed mechanisms include blood vessel growth, cell migration, cell survival, growth factor signalling and nitric oxide effects.
What are the stages of tissue healing?
Inflammation, proliferation and remodelling. Proposed BPC-157 effects would mainly act during proliferation.
Does BPC-157 improve athletic performance?
That claim is not supported by published research. Recovery studies look at healing after injury in research models, and BPC-157 is banned in sport.
Why use several outcome measures?
Because structure, strength and function do not always change together, so several measures give a more reliable picture.
Is there strong clinical evidence?
No. Clinical evidence is very limited and of low quality.
Is BPC-157 approved for recovery?
No. It is not an approved medicine for any use.
Is BPC-157 for personal use?
No. It is supplied for laboratory research only.
References
- Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS J (2025). PubMed PMID 40756949
- Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J Orthop Res (2003). PubMed PMID 14554208
- Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing. Curr Rev Musculoskelet Med (2025). PubMed PMID 40789979
For laboratory research use only. Nothing on this page is medical advice, and none of our compounds are for human or animal consumption. Questions about a batch, a Certificate of Analysis or an order can go to [email protected].